Fig. 7From: Cancer immune control dynamics: a clinical data driven model of systemic immunity in patients with metastatic melanomaTop modulator-source doublets enhanced in cancer patients compared to healthy controls. a From CICD analysis, the ten modulator-source doublets with the greatest difference between cancer patients and healthy controls are shown. b The top modulator chemokines in cancer patient peripheral blood are IL-8, IP-10, and MCP-1, which play a role in cancer immunityBack to article page